To provide leadership and a multi-stakeholder, collaborative platform for the Medical Device and Diagnostic community to address opportunities, issues and challenges impacting the policy, economic evaluation, and payment landscape for the device and diagnostic space.
- Develop and disseminate best practices in outcome research of medical technologies
- Promote scientific discussions on relevant topics for devices and diagnostics
- Prioritize, develop and promote research and education related to medical devices and diagnostics.
- Provide an international network of stakeholders to advance the validation, adoption and utilization of medical devices and diagnostics.
Medical devices and diagnostics account for roughly a quarter of hospital technology expenditures and are a rapidly growing technology field. There is a broad group of stakeholders affected by the medical device and diagnostics marketplace that is relevant to ISPOR, including scientists, economists, manufacturers, policy makers, clinicians, HTA organizations, payers, procurement, media, advocacy organizations and patients. Efforts to define market value of medical devices and diagnostics are confounded by several factors especially a scarcity of verifiable evidence in the early and mid-stages of product commercialization. Difficulty in performing timely and reliable assessments compounded with fragmented and diverse payment pathways, can limit market access and reimbursement. It is critical to advance this dialogue with multiple stakeholders to ensure appropriate provider and patient access, while ensuring healthcare system value for money.
Ulises Garay, MSc, BEc
Arthi Chandran, MS, BS, DrPH, MPH
Richard Charter, MSc
Stakeholder Perspectives on Assessing the Value of Medical Devices
- Michael J Cangelosi, Associate Director, Health Economics, Boston Scientific
- Akriti Chahar, MA, MSc, PhD, Consultant Health Economics Outcome Research, IQVIA
- Simon Eggington, MSc, Health Policy Consultant, Medtronic
Health Technology Assessment of Next Generation Diagnostic Testing Approaches
Joint project with the Precision Medicine and Advanced Therapies Special Interest Group
- Daryl S. Spinner, PhD, MBA – Vice President, Market Access and Reimbursement, Variantyx, Inc
- Susan M. Snyder, PhD, MBA – Associate Professor, Health Policy & Behavioral Sciences, Georgia State University School of Public Health
- Bettina Zimmermann, BS, Access Global Lead, Roche, Basel, Switzerland
- Bjoern Schwander, RN, BSc, MA, General Manager, AHEAD GmbH
- Rana Maroun, PhD, Principal Quantitative Scientist HEOR – Real World Data Team, Hoffmann-La Roche, Basel, Switzerland
- Adam F. Gaertner, BA, Sr. Manager, Market Access and Health Economics, Baxter Healthcare, USA
- Abdalla Abotaleb, BSc, MBA, PhD, Project Manager, WHO
- Assessing the Value of Medical Devices—Choosing the Best Path Forward: Where Do We Go From Here?
- Health Technology Assessment for Molecular Diagnostics: Practices, Challenges and Recommendations from the Medical Devices and Diagnostic Special Interest Group
- Journal Club presentation of: The Value of Diagnostic Information in Personalised Healthcare: A Comprehensive Concept to Facilitate Bringing This Technology into Healthcare Systems